ALPhANOV is partner of the European project ATLANTIC KET MED. This 3-year project is funded by the INTERREG ATLANTIC AREA program and has a global budget of 2.7M €.
ATLANTIC KET MED is an international consortium composed by 7 partners located in Ireland, Portugal, Spain, the United Kingdom and France with ALPhANOV. The consortium brings together a wide range of recognized expertise from all six key-enabling-technologies (KET) defined by Europe: micro-nanoelectronics, nanotechnologies, photonics, biotechnologies, advanced materials, and advanced manufacturing processes.
The main objective of the ATLANTIC KET MED project is to set up a transnational ecosystem, bringing together companies in the Atlantic Region involved in the biomedical sector. ATLANTIC KET MED offers support in their new developments, in order to meet the technological challenges of tomorrow.
The launch meeting of the ATLANTIC KET MED project, attended by all partners, took place in Nantes, on November 15th, 2017.